Current understanding of the epidemiology and clinical implications of BRCA1 and BRCA2 mutations for ovarian cancer
- 1 February 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Obstetrics and Gynecology
- Vol. 14 (1) , 19-26
- https://doi.org/10.1097/00001703-200202000-00004
Abstract
Genetic testing for susceptibility to ovarian cancer is rapidly becoming integrated into the clinical practice of oncology. Genetic testing for BRCA1 and BRCA2 is now recommended to most women with invasive ovarian cancer. Approximately 10% of these women will have a positive test, including 4% of women without a family history of cancer. Currently, the treatment of hereditary ovarian cancer is the same as for non-hereditary ovarian cancer. It appears that women with ovarian cancer and a BRCA mutation experience better survival than women without a mutation, possibly due to enhanced susceptibility to chemotherapy. Strategies for prevention of ovarian cancer among carriers include oral contraceptives, tubal ligation and prophylactic oophorectomy.Keywords
This publication has 45 references indexed in Scilit:
- Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of aBRCA1orBRCA2MutationNew England Journal of Medicine, 2001
- Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian CancerAmerican Journal of Human Genetics, 2001
- Variation in Cancer Risks, by Mutation Position, in BRCA2 Mutation CarriersAmerican Journal of Human Genetics, 2001
- Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutationsHuman Pathology, 2000
- Occult Ovarian Tumors in Women With BRCA1 or BRCA2 Mutations Undergoing Prophylactic OophorectomyJournal of Clinical Oncology, 2000
- Clinicopathologic Features of BRCA-Linked and Sporadic Ovarian CancerJAMA, 2000
- BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian CancerAmerican Journal of Human Genetics, 2000
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden.Journal of Clinical Oncology, 1998
- Microscopic Benign and Invasive Malignant Neoplasms and a Cancer-Prone Phenotype in Prophylactic OophorectomiesJNCI Journal of the National Cancer Institute, 1996